HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

Updated on: April 16,2024

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

Updated on:April 16,2024

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on: March 27,2024

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on:March 27,2024

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on: April 22,2024

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on:April 22,2024

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte

Updated on: April 01,2024

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte

Updated on:April 01,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on: November 15,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on:November 15,2024

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display

Updated on: January 26,2024

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display

Updated on:January 26,2024

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow

Updated on: January 26,2024

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow

Updated on:January 26,2024

Researchers find a clue to fighting fatal influenza

by Hudson Institute of Medical ResearchGSDMD deficiency limits the severity of IAV infection. Credit:Cell Death & Disease(2023). DOI: 10.1038/s41419-023-06258-1When influenza (or

Updated on: January 28,2024

Researchers find a clue to fighting fatal influenza

by Hudson Institute of Medical ResearchGSDMD deficiency limits the severity of IAV infection. Credit:Cell Death & Disease(2023). DOI: 10.1038/s41419-023-06258-1When influenza (or

Updated on:January 28,2024

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and

Updated on: October 01,2024

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and

Updated on:October 01,2024

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on: June 14,2024

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on:June 14,2024

Drug repurposing research offers new hope in the fight against RSV

by Jan Grabowski, Zentrum für Experimentelle und Klinische InfektionsforschungIdentification of drug repurposing candidates.AScreening and validation procedure.BHEp-2 cells wer

Updated on: May 21,2024

Drug repurposing research offers new hope in the fight against RSV

by Jan Grabowski, Zentrum für Experimentelle und Klinische InfektionsforschungIdentification of drug repurposing candidates.AScreening and validation procedure.BHEp-2 cells wer

Updated on:May 21,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on: November 29,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on:November 29,2024